Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30055939HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055940HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055941HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS20040704HPVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS44043072HTLV-1ENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS44048213HTLV-1ENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS44048233HTLV-1ENSG00000186951.17protein_codingPPARANoNo5465Q07869
TCGA Plot Options
Drug Information
GenePPARA
DrugBank IDDB08915
Drug NameAleglitazar
Target IDBE0000071
UniProt IDQ07869
Regulation Typeagonist
PubMed IDs20653327; 10592235
CitationsCavender MA, Lincoff AM: Therapeutic potential of aleglitazar, a new dual PPAR-alpha/gamma agonist: implications for cardiovascular disease in patients with diabetes mellitus. Am J Cardiovasc Drugs. 2010;10(4):209-16. doi: 10.2165/11539500-000000000-00000.@@Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsInvestigational
Direct ClassificationPhenyl-1,3-oxazoles
SMILESCO[C@@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C2=C1SC=C2)C(O)=O
Pathways
PharmGKB
ChEMBLCHEMBL519504